Skip to main content
Log in

Bestimmung der Inhibition der mitochondrialen Biogenese

  • Anwendungen & Produkte
  • In-Cell-ELISA
  • Published:
BIOspektrum Aims and scope

Abstract

Mitochondria are produced from the transcription and translation of genes both in the nuclear genome and in the mitochondrial genome, termed mitobiogenesis. Measuring mitobiogenesis is useful for early toxicity screening of new drug candidates. This requires an assay that is quantitative, specific, and reproducible and is also flexible enough to be applied in a variety of cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Food and Drug Administration (2006) Guidance for Industry; Antiviral Product Development — Conducting and Submitting Virology Studies to the Agency. www.fda.gov/OHRMS/DOCKETS/98fr/05d-0183-gdl0002-01.pdf

  2. Food and Drug Administration (2009) Guidance for Industry; Drug-Induced Liver Injury: Premarketing Clinical Evaluation. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf

  3. Medeiros, DM (2008) Assessing mitochondria biogenesis. Methods 46:288–294

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James Murray.

Additional information

James Murray, Daniel Schwartz und Jan Hryca (v. l. n. r.)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, J., Schwartz, D. & Hryca, J. Bestimmung der Inhibition der mitochondrialen Biogenese. Biospektrum 18, 60–61 (2012). https://doi.org/10.1007/s12268-012-0145-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-012-0145-4

Navigation